LILLY FDA Approval ANDA 062549

ANDA 062549

LILLY

FDA Drug Application

Application #062549

Application Sponsors

ANDA 062549LILLY

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INJECTIONEQ 1GM BASE/VIAL0KEFLIN IN PLASTIC CONTAINERCEPHALOTHIN SODIUM
002INJECTABLE;INJECTIONEQ 2GM BASE/VIAL0KEFLIN IN PLASTIC CONTAINERCEPHALOTHIN SODIUM

FDA Submissions

ORIG1AP1985-09-10
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1992-10-30

Submissions Property Types

ORIG1Null0
SUPPL6Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62549
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.